BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210323
DTEND;VALUE=DATE:20210325
DTSTAMP:20201203T003554Z
CREATED:20201203T003554Z
LAST-MODIFIED:20201203T003554Z
UID:4682-1616457600-1616630399@carb-x.org
SUMMARY:3rd Bacteriophage Therapy Summit 2021
DESCRIPTION:The 3rd Bacteriophage Therapy Summit returns! With a new looking speaker line-up and never before seen content\, we are excited to continue to unite the community to progress fundamental bacteriophage research into clinically-significant products. \nThe overuse of antibiotics had led to the development of multi-resistant bacterial strains\, most notably ESKAPE pathogens\, rendering the use of antibiotics\, which in many scenarios are useless. However\, bacteriophages may hold the key in overcoming the global antibiotic resistance crisis. \nAlthough the potential use of phage and phage-derived products in a clinical setting is beginning to be understood\, there still remains a number of unique challenges associated with this novel therapeutic agent. A developing regulatory landscape\, up-scaling of manufacturing processes\, and the design of clinical trials are just a few of the roadblocks holding back development. \nBringing together leading drug developers\, academics and clinical researchers\, our agenda is focused to address the main translation challenges from characterization of phages through to clinical development. This is your opportunity to join your peers to strengthen your product development pipelines and forge new collaborations to unlock the full potential of bacteriophage therapeutics. \nCARB-X participants include Richard Alm\, Alliance Director. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/3rd-bacteriophage-therapy-summit-2021/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210312T110000
DTEND;TZID=America/New_York:20210312T130000
DTSTAMP:20210210T172607Z
CREATED:20201203T001344Z
LAST-MODIFIED:20210210T172607Z
UID:4678-1615546800-1615554000@carb-x.org
SUMMARY:BARDA AMR Vaccine Public Workshop: Vaccines against AMR Threats
DESCRIPTION:Multi-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential to combat the growing crisis.  Every year\, 2.8 million American develop a drug resistant infection and 35\,000 people die. Globally\, MDR infections kill 700\,000 each year – current estimates are that MDR organisms will kill more than 10 million a year by 2050 if left unchecked. \nBARDA supports development and procurement of medical countermeasures to protect Americans against chemical\, biological\, radiological\, and nuclear (CBRN) threats. MDR does not discriminate\, and victims of CBRN events are at risk of suffering fatal complications from drug resistant infections. One of BARDA’s top priorities is to develop a vaccine to protect people from these threats. \nHelp BARDA fight AMR! Join the workshop to learn more about BARDA\, our mission\, and how we plan to tackle this growing threat. The event will consist of presentations from BARDA experts\, followed by a structured discussion\, and Q&A. Companies and others interested in working with BARDA are encouraged to attend the March 12\, 2021 workshop. The event is open to the public\, but space is limited. Be sure to register by March 5\, 2021. Please\, no more than four people from one organization. Are you a product developer working on a vaccine against one of the four targeted pathogens? Then we want to talk with you! Be sure to request a private meeting when you register for the workshop. \nCARB-X participants include Kevin Outterson\, Executive Director. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/pandemic-prevention-and-innovation-summit-identifying-opportunities-for-investment-collaboration-in-ensuring-future-pandemic-preparedness/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T100000
DTEND;TZID=America/New_York:20210304T113000
DTSTAMP:20210223T151424Z
CREATED:20210223T151424Z
LAST-MODIFIED:20210223T151424Z
UID:5022-1614852000-1614857400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Learning from COVID-19 to tackle the silent pandemic of antibiotic resistance
DESCRIPTION:The COVID-19 pandemic has brought into sharp focus the impact of pandemics. The novel coronavirus has claimed more than a million lives\, trillions of dollars have been lost\, expenditures cut and international efforts to achieve the Sustainable Development Goals put in jeopardy. \nCOVID-19 has demonstrated pandemic preparedness requires a global coordinated effort\, and no country can do it alone. Strengthening our ability to fight the silent pandemic of drug-resistant infections must also ensure affordable access to vital health tools\, including new and improved treatments. This webinar will focus on how we can apply the lessons learned from COVID-19 to tackle drug resistance and ensure access to appropriate antibiotics. \nSpeakers:  \n\nManica Balasegaram\, GARDP\nJoanne Liu\, University of Montreal and Médecins Sans Frontières\nMarc Mendelson\, Groote Schuur Hospital\, University of Cape Town\n\nModerator: Claire Doole \nThe presentations will be followed by a Q&A session. \nClick here to learn more and register.
URL:https://carb-x.org/event/live-webinar-gardp-revive-learning-from-covid-19-to-tackle-the-silent-pandemic-of-antibiotic-resistance/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210224
DTEND;VALUE=DATE:20210227
DTSTAMP:20201202T235219Z
CREATED:20201202T235219Z
LAST-MODIFIED:20201202T235219Z
UID:4677-1614124800-1614383999@carb-x.org
SUMMARY:Phage Futures Congress
DESCRIPTION:Join us at the International Phage Futures Congress in 2021\, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond. Discover how you can be at the forefront of the developing phage therapy market. Network & learn from established biotech companies\, emerging start-ups\, leading academics\, global accelerator representatives\, investment firms\, international healthcare organisations & regulatory bodies. \nAmong other topics\, expect to hear & participate in: \n\nAdvice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic & acute illnesses.\nRegulatory discussions between international governing bodies with region specific follow-up conversations with the experts.\nInsights into new fields for phage application\, such as oncology\, diagnostics & microbial gene therapy.\nExpert advice on how to find & secure financial investments.\n\nCARB-X participants include Richard Alm\, Alliance Director. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/phage-futures-congress/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210222
DTEND;VALUE=DATE:20210227
DTSTAMP:20210216T143312Z
CREATED:20210216T143312Z
LAST-MODIFIED:20210216T143312Z
UID:4998-1613952000-1614383999@carb-x.org
SUMMARY:The Bloomsbury SET Conference on Infectious Disease and AMR
DESCRIPTION:The Bloomsbury SET is hosting its first virtual conference focused on knowledge exchange and infectious disease during the 22nd to 26th February 2021. \nThroughout the week\, the Bloomsbury SET and wider partners will explore interdisciplinary innovation\, research translation\, commercialisation\, impact and connecting capabilities to tackle global health challenges through knowledge exchange.  \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/the-bloomsbury-set-conference-on-infectious-disease-and-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210202T100000
DTEND;TZID=America/New_York:20210202T120000
DTSTAMP:20210127T230630Z
CREATED:20210127T225936Z
LAST-MODIFIED:20210127T230630Z
UID:4898-1612260000-1612267200@carb-x.org
SUMMARY:C-CAMP AMR Webinar Series: Pre-Clinical and Early Drug Development in India
DESCRIPTION:India is fast emerging as one of the global hubs for conducting pre- clinical and clinical development. The webinar will showcase the competencies of some of the CROs\nin India and how Product Developers can leverage the advantages of working with Indian CROs.  \nParticipating CROs include: \n\nBioneeds India\nSyngene International\nSIRO Clinpharm\nSai Life Sciences\nGVK Bio\n\nClick here to learn more and register.\nClick here to view the zoom link.
URL:https://carb-x.org/event/c-camp-amr-webinar-series-pre-clinical-and-early-drug-development-in-india/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210202
DTEND;VALUE=DATE:20210204
DTSTAMP:20201203T002040Z
CREATED:20201203T002040Z
LAST-MODIFIED:20201203T002040Z
UID:4679-1612224000-1612396799@carb-x.org
SUMMARY:BSAC/GARDP Antimicrobial Chemotherapy Virtual Conference 2021
DESCRIPTION:Jointly organised by the BSAC and GARDP. For 2021\, the conference collaborators are the Helmholtz Institute for Pharmaceutical Sciences (HIPS)\, the German Center for Infection Research (DZIF) and the International Research Alliance for Antibiotic Discovery and Development (IRAADD) (a JPIAMR funded network) \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/bsac-gardp-antimicrobial-chemotherapy-virtual-conference-2021/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210126
DTEND;VALUE=DATE:20210129
DTSTAMP:20201207T214811Z
CREATED:20201202T234806Z
LAST-MODIFIED:20201207T214811Z
UID:4670-1611619200-1611878399@carb-x.org
SUMMARY:4th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference
DESCRIPTION:Please make plans to join us for this outstanding line-up of internationally-renowned experts in antimicrobial resistance and stewardship. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/skip-to-content-4th-annual-texas-medical-center-antimicrobial-resistance-and-stewardship-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210121
DTEND;VALUE=DATE:20210122
DTSTAMP:20201207T214641Z
CREATED:20201202T233345Z
LAST-MODIFIED:20201207T214641Z
UID:4666-1611187200-1611273599@carb-x.org
SUMMARY:Innovative Medicines Initiative (IMI) ENABLE Annual Meeting
DESCRIPTION:Antimicrobial resistance (AMR) is a major public health threat. Infections caused by resistant bacteria are increasing and causing Europe to face soaring costs both in terms of lives and public health expenditure. Despite the strong need for new antimicrobials\, very few new\, effective antibiotics have been brought to the market in the last decades. The ENABLE project\, within IMI’s New Drugs for Bad Bugs (ND4BB) programme\, is working to advance the development of potential antibiotics against Gram-negative bacteria\, such as Escherichia coli. The ultimate goal of the project is to develop attractive antimicrobial candidates for testing in the clinic\, bringing the possibility of new antibiotics to treat Gram-negative infections one step closer to patients. \nCARB-X participants include Erin Duffy\, Chief of R&D.  \nClick here to learn more.
URL:https://carb-x.org/event/innovative-medicines-initiative-imi-enable-annual-meeting-emd/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210118
DTEND;VALUE=DATE:20210121
DTSTAMP:20201202T234358Z
CREATED:20201202T234358Z
LAST-MODIFIED:20201202T234358Z
UID:4671-1610928000-1611187199@carb-x.org
SUMMARY:Keystone Symposia: Harnessing the Microbiome for Disease Prevention and Therapy
DESCRIPTION:Joint meeting with: The Microbiome: From Mother to Child\nJanuary 18-20\, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET* \nOur understanding of the microbiome is advancing rapidly\, and continues to productively move through the discovery phase\, with numerous correlations being established between specific commensal microbes or microbiota compositions and a wide range of diseases that includes infections\, inflammatory conditions\, metabolic disease\, autoimmunity and neurologic syndromes. The initial discovery of these potentially important correlations has led many laboratories around the world to probe the molecular mechanisms that form the causal link between specific commensal microbes and disease development\, progression and resolution. Although there have been great advances\, culturing many of the prevalent and metabolically active obligate anaerobic commensals remains a challenge. Exciting advances\, however\, are emerging from laboratories developing tools to genetically manipulate key commensal organisms\, facilitating experimental studies that are identifying the small\, bioactive molecules they produce\, some of which have therapeutic potential. Studies of the impact of bacteriophage on the microbiota also suggest that they may have therapeutic potential. This Keystone conference will focus on recent advances that demonstrate\, at the cellular and molecular level\, the impact of the microbiota and its products on disease susceptibility/resistance\, with an emphasis on microbial and host metabolism\, inter-microbial interactions and the amelioration of diseases. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/keystone-symposia-harnessing-the-microbiome-for-disease-prevention-and-therapy/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210105
DTEND;VALUE=DATE:20210106
DTSTAMP:20201202T233753Z
CREATED:20201202T233712Z
LAST-MODIFIED:20201202T233753Z
UID:4672-1609804800-1609891199@carb-x.org
SUMMARY:National Academy of Science
DESCRIPTION:The National Academy of Sciences (NAS) is a private\, nonprofit organization of the country’s leading researchers. The NAS recognizes and promotes outstanding science through election to membership; publication in its journal\, PNAS; and its awards\, programs\, and special activities. Through the National Academies of Sciences\, Engineering\, and Medicine\, the NAS provides objective\, science-based advice on critical issues affecting the nation. \nCARB-X participants include Kevin Outterson\, Executive Director. \nClick here to learn more.
URL:https://carb-x.org/event/national-academy-of-science/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201212
DTSTAMP:20201202T232424Z
CREATED:20201202T232424Z
LAST-MODIFIED:20201202T232424Z
UID:4665-1607299200-1607731199@carb-x.org
SUMMARY:2020 ASM Conference on Next-Generation Sequencing
DESCRIPTION:Join us at the virtual 2020 ASM Conference on Next-Generation Sequencing\, taking place Dec. 7-11\, 2020\, and get comprehensive guidance with up-to-date examples in the use of NGS technology for applied results in the traceability and clustering of microbial pathogens associated with food safety\, clinical infection\, environmental contamination and other potential sources of disease outbreaks. You’ll walk away with access to the available resources and direction you need relating to bioinformatics and epidemiology. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/2020-asm-conference-on-next-generation-sequencing/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201202
DTEND;VALUE=DATE:20201205
DTSTAMP:20201202T232133Z
CREATED:20201202T232133Z
LAST-MODIFIED:20201202T232133Z
UID:4664-1606867200-1607126399@carb-x.org
SUMMARY:Infectious Diseases Virtual Partnering
DESCRIPTION:Infectious diseases have always impacted human history\, but in the past 50 years we have managed to control or eliminate some infectious diseases through improved hygiene\, vaccination\, antimicrobials\, advances in medicine and public health policies. However\, the current pandemic is a reminder that we need to continue to pursue our efforts to control these pathogens\, especially with intercontinental travel and increased mobility of people and animals. \nTo manage infectious diseases\, we use tools such as vaccines\, antibiotics\, antivirals\, diagnostic tools and biomarkers. But today there are many infectious diseases for which we do not have satisfactory preventive tools or treatment options\, such as SARS-CoV-2\, Zika virus\, Ebola virus\, multidrug resistant bacteria\, HIV\, Malaria. To develop these future tools\, collaboration is essential\, either for sourcing assets in the vaccine\, antiviral or antibiotic space\, or for finding research tools to help in screening\, in-vivo modelling\, clinical trials and diagnostics and biomarkers. \nIt is in this context that we are organising the Infectious Diseases Virtual Partnering event\, focusing on diseases caused by organisms such as bacteria\, viruses\, fungi\, or parasites. With current travel restrictions\, this virtual event will help you to find the right business partner to pursue your objectives.  This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise\, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/infectious-diseases-virtual-partnering/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201202
DTEND;VALUE=DATE:20201203
DTSTAMP:20201202T230539Z
CREATED:20201202T230539Z
LAST-MODIFIED:20201202T230539Z
UID:4663-1606867200-1606953599@carb-x.org
SUMMARY:Global AMR Hub Virtual Conference
DESCRIPTION:Translating AMR R&D mapping into policy and action.\nThe Global AMR R&D Hub\, through its Dynamic Dashboard\, is the global knowledge centre for AMR R&D. The Dynamic Dashboard captures and presents: AMR R&D investments from across the globe and One Health sectors; what new antibacterials are in the pipeline; and what is being done to overcome the challenges hindering the development of\, and access to and stewardship of\, priority antibacterials. The important next step for the Global AMR R&D Hub is to take the repository of information\, that is the Dynamic Dashboard\, and translate this into policy and action. \nThis virtual conference is the start of this next important step for the Global AMR R&D Hub. The virtual conference begins discussions to inform how the Global AMR R&D Hub\, using its Dynamic Dashboard\, can support the AMR R&D needs in the different regions and countries\, by highlighting gaps that need to be filled and helping to identify collaboration or partnership opportunities. The three sessions of the conference focus on three different areas to do this: \nCARB-X participants include Kevin Outterson\, Executive Director\, and Erin Duffy\, Chief of Research & Development. \nClick here to learn more.
URL:https://carb-x.org/event/global-amr-hub-virtual-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
END:VCALENDAR